FDA granted an orphan drug designation for APTO-253 for the treatment of acute myeloid leukemia.
Merck Canada Inc. announced that Keytruda (pembrolizumab) was authorized for sale with conditions by Health Canada.
KAREN KNUDSEN was named director of the Sidney Kimmel Cancer Center at Thomas Jefferson University.
THE AMERICAN ASSOCIATION FOR CANCER RESEARCH and Bayer HealthCare announced a partnership to expand AACR's Basic Cancer Research Fellowship Program for 2015.
THE PEW CHARITABLE TRUSTS named 22 early-career researchers as Pew scholars in the biomedical sciences—as well as five scholars for cancer research, funded in partnership with the Alexander and Margaret Stewart Trust.
THE CANCER GENOME ATLAS Research Network, including more than 300 researchers from 44 institutions, found that molecular diagnostics are much more precise and reproducible than looking at tissue under a microscope for classification of diffuse gliomas.
A pediatric oncologist at MD Anderson Cancer Center is facing federal charges of one count of receiving and possessing child pornography.
MARY BECKERLE was appointed to the board of directors of Johnson & Johnson. Beckerle will serve on the board's Science, Technology & Sustainability Committee.
ROBERTO PILI joined the Indiana University Melvin and Bren Simon Cancer Center. Pili will direct the genitourinary research program at the cancer center and serve as the medical director of the genitourinary clinical program at the IU Health Simon Cancer Center.
Could the Supreme Court functionally end Obamacare before the end of June?
